Cambrex Corp., of East Rutherford, N.J., appointed David DeMarco vice president, strategic planning.
Cambridge Biostability Ltd., of Cambridge, UK, appointed Michael Darsley director of vaccine development.
Chiron Corp., of Emeryville, Calif., said the National Academy of Sciences elected Chief Scientific Officer Rino Rappuoli for membership in the academy as a foreign associate. Craig Wheeler, president of Chiron BioPharmaceuticals, was elected to the California Healthcare Institute's board.
Cornerstone BioPharma Inc., of Cary, N.C., appointed Brian Dickson chief medical officer.
Cylex Inc., of Columbia, Md., appointed Michael Petruny vice president of sales.
Dragon Pharmaceutical Inc., of Vancouver, British Columbia, appointed Xiaochun Zhang general manager of Chinese operations.
Eximias Pharmaceutical Corp., of Berwyn, Pa., appointed Gerard Kennealey senior vice president and chief medical officer.
Genentech Inc., of South San Francisco, appointed Peter Carberry vice president, clinical operations, and promoted Charles Calderaro to vice president, corporate engineering, and Todd Rich to vice president, clinical and commercial regulatory affairs.
Genitope Corp., of Redwood City, Calif., appointed David Miller vice president of information technology, and promoted Laura Woodhead to vice president of legal affairs.
Illumina Inc., of San Diego, appointed Christian Henry vice president and chief financial officer, and promoted Kirk Malloy to vice president of customer solutions.
Imagenetix Inc., of San Diego, appointed Jason Theodosakis and Lorna Vanderhaeghe to its scientific and medical advisory board.
ImaRx Therapeutics Inc., of Tucson, Ariz., appointed Randall Miller chief operating officer, and Greg Cobb chief financial officer.
ImmunoGen Inc., of Cambridge, Mass., appointed Daniel Junius chief financial officer and senior vice president, finance.
Inspire Pharmaceuticals Inc., of Durham, N.C., appointed Joseph Spagnardi vice president and deputy general counsel.
Invitrogen Corp., of Carlsbad, Calif., promoted Mark Gardner to chief marketing officer.
Large Scale Biology Corp., of Vacaville, Calif., appointed Ulrich Grau to its board.
Linguagen Corp., of Cranbury, N.J., appointed Robert Margolskee, David Floyd, Sue Kinnamon and Stephen Roper to its scientific advisory board.
MacroPore Biosurgery Inc., of San Diego, appointed Douglas Arm vice president of development for regenerative cell technology, and Kai Pinkernell director of clinical applications.
Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Tony Scullion full-time executive chairman.
Merrimack Pharmaceuticals Inc., of Cambridge, Mass., appointed Gary Crocker chairman.
Mylan Laboratories Inc., of Pittsburgh, appointed Patrick Fitzgerald vice president, public relations.
Nektar Therapeutics, of San Carlos, Calif., appointed Joseph Krivulka to its board.
Neose Technologies Inc., of Horsham, Pa., named Stephen Roth director emeritus.
Newron Pharmaceuticals SpA, of Milan, Italy, appointed Stefan Weber chief financial officer, and Ravi Anand chief medical officer.
Palatin Technologies Inc., of Cranbury, N.J., appointed Trevor Hallam executive vice president, research and development.